FABP4 and Insulin resistance: We and other authors have shown that FABP4 levels are increased in obesity, metabolic syndrome (MS), type 2 diabetes (T2D), and familial combined hyperlipidaemia or lipodystrophy syndromes and that these increased levels are also closely correlated with adverse lipid profiles and insulin resistance[8-14].